"Neoplasm Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
| Descriptor ID |
D009363
|
| MeSH Number(s) |
D12.776.624
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Proteins".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Proteins".
This graph shows the total number of publications written about "Neoplasm Proteins" by people in this website by year, and whether "Neoplasm Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 6 | 3 | 9 |
| 1997 | 2 | 3 | 5 |
| 1998 | 3 | 3 | 6 |
| 1999 | 7 | 1 | 8 |
| 2000 | 8 | 6 | 14 |
| 2001 | 6 | 2 | 8 |
| 2002 | 5 | 6 | 11 |
| 2003 | 7 | 6 | 13 |
| 2004 | 11 | 8 | 19 |
| 2005 | 6 | 13 | 19 |
| 2006 | 12 | 4 | 16 |
| 2007 | 12 | 11 | 23 |
| 2008 | 9 | 10 | 19 |
| 2009 | 10 | 6 | 16 |
| 2010 | 6 | 5 | 11 |
| 2011 | 12 | 6 | 18 |
| 2012 | 10 | 6 | 16 |
| 2013 | 10 | 4 | 14 |
| 2014 | 17 | 9 | 26 |
| 2015 | 21 | 8 | 29 |
| 2016 | 7 | 4 | 11 |
| 2017 | 14 | 10 | 24 |
| 2018 | 19 | 7 | 26 |
| 2019 | 16 | 8 | 24 |
| 2020 | 9 | 2 | 11 |
| 2021 | 14 | 7 | 21 |
| 2022 | 1 | 1 | 2 |
| 2023 | 0 | 5 | 5 |
| 2024 | 2 | 3 | 5 |
| 2025 | 2 | 1 | 3 |
| 2026 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Proteins" by people in Profiles.
-
Oncocytic Intraductal Carcinoma of the Parotid Gland with STRN::ALK Fusion. Head Neck Pathol. 2026 Jun 30; 20(1).
-
Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade Cancers. J Pediatr Hematol Oncol. 2021 Oct 01; 43(7):e987-e990.
-
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation. J Clin Invest. 2021 01 04; 131(1).
-
Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer. J Clin Invest. 2021 01 04; 131(1).
-
X-aptamers targeting Thy-1 membrane glycoprotein in pancreatic ductal adenocarcinoma. Biochimie. 2021 Feb; 181:25-33.
-
Hoxd10 Is Required Systemically for Secretory Activation in Lactation and Interacts Genetically with Hoxd9. J Mammary Gland Biol Neoplasia. 2020 06; 25(2):145-162.
-
Small molecule JQ1 promotes prostate cancer invasion via BET-independent inactivation of FOXA1. J Clin Invest. 2020 04 01; 130(4):1782-1792.
-
Proteome alterations in pancreatic ductal adenocarcinoma. Cancer Lett. 2020 01 28; 469:429-436.
-
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma. Genome Res. 2019 08; 29(8):1211-1222.
-
Paralog Studies Augment Gene Discovery: DDX and DHX Genes. Am J Hum Genet. 2019 08 01; 105(2):302-316.